Regulatory Filings • Mar 17, 2020
Regulatory Filings
Open in ViewerOpens in native device viewer
With the rise in Covid-19 cases, the Malaysian government has declared that the entire country will be on a movement control order starting 18 March, 2020 and expected to end on 31 March, 2020. Ambu owns and operates a manufacturing plant in Malaysia where a.o. Ambu's single-use endoscopes are being manufactured. It is currently uncertain whether this order will also apply to the factory or the factory can be exempt as our aScope is one of the few guaranteed sterile bronchoscopes available if you need to do a bronchoscopy despite the Covid-19 situation.
Even in a situation where the Ambu factory in Malaysia will be subject to the movement control order, we expect to have sufficient inventories of aScope and most other products manufactured at the site to avoid any significant disruption to the supply chain within the duration of the movement order.
Assuming that the movement control order expires as stated on 31 March, 2020, we expect that the impact from the Malaysian government action will not have material impact on our guidance as provided at Q1 on 4 February, 2020.
Michael Højgaard, CFO, tel. +45 4030 4349, email: [email protected] Nicolai Thomsen, Investor Relations Manager, tel. +45 2620 8047, email: [email protected]
Mikkel Trier Wagner, Director Corporate Communications, tel. +45 4191 0830, email: [email protected]
Ambu A/S Baltorpbakken 13, 2750 Ballerup, Denmark Tel. +45 7225 2000, CVR no.: 63 64 49 19 www.ambu.com
Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring & diagnostics solutions. The manifestations of our efforts have ranged from early innovations like the Ambu® Bag™ resuscitator and the Ambu® BlueSensor™ electrodes to our newest landmark solutions like the Ambu® aScope™ – the world's first single-use flexible endoscope. Moreover, we continuously look to the future with a commitment to deliver innovative quality products that have a positive impact on the work of doctors, nurses and paramedics. Headquartered near Copenhagen in Denmark, Ambu employs approximately 3,000 people in Europe, North America and the Asia Pacific. For more information, please visit ambu.com.
Company announcement no. 7 2019/20 17 March 2020 Page 1 of 1
Have a question? We'll get back to you promptly.